Sims AH - Search Results

1

Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.

Lawrenson K, Sproul D, Grun B, Notaridou M, Benjamin E, Jacobs IJ, Dafou D, Sims AH, Gayther SA. Lawrenson K, et al. Among authors: sims ah. Carcinogenesis. 2011 Oct;32(10):1540-9. doi: 10.1093/carcin/bgr140. Epub 2011 Aug 22. Carcinogenesis. 2011. PMID: 21859834

2

Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.

Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, Harrison DJ, Meehan RR, Sims AH, Ramsahoye BH. Sproul D, et al. Among authors: sims ah. Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4364-9. doi: 10.1073/pnas.1013224108. Epub 2011 Feb 28. Proc Natl Acad Sci U S A. 2011. PMID: 21368160 Free PMC article.

3

Targeting of Rac GTPases blocks the spread of intact human breast cancer.

Katz E, Sims AH, Sproul D, Caldwell H, Dixon MJ, Meehan RR, Harrison DJ. Katz E, et al. Among authors: sims ah. Oncotarget. 2012 Jun;3(6):608-19. doi: 10.18632/oncotarget.520. Oncotarget. 2012. PMID: 22689141 Free PMC article.

4

Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns.

Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR. Sproul D, et al. Among authors: sims ah. Genome Biol. 2012 Oct 3;13(10):R84. doi: 10.1186/gb-2012-13-10-r84. Genome Biol. 2012. PMID: 23034185 Free PMC article.

5

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.

Taylor KJ, Sims AH, Liang L, Faratian D, Muir M, Walker G, Kuske B, Dixon JM, Cameron DA, Harrison DJ, Langdon SP. Taylor KJ, et al. Among authors: sims ah. Breast Cancer Res. 2010;12(3):R39. doi: 10.1186/bcr2593. Epub 2010 Jun 22. Breast Cancer Res. 2010. PMID: 20569502 Free PMC article.

6

An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer.

Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, Harrison DJ. Katz E, et al. Among authors: sims ah. PLoS One. 2011 Feb 15;6(2):e17083. doi: 10.1371/journal.pone.0017083. PLoS One. 2011. PMID: 21347235 Free PMC article.

7

Cyclin D1, Id1 and EMT in breast cancer.

Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G. Tobin NP, et al. Among authors: sims ah. BMC Cancer. 2011 Sep 28;11:417. doi: 10.1186/1471-2407-11-417. BMC Cancer. 2011. PMID: 21955753 Free PMC article.

8

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.

Sims AH, Zweemer AJ, Nagumo Y, Faratian D, Muir M, Dodds M, Um I, Kay C, Hasmann M, Harrison DJ, Langdon SP. Sims AH, et al. Br J Cancer. 2012 May 22;106(11):1779-89. doi: 10.1038/bjc.2012.176. Epub 2012 May 1. Br J Cancer. 2012. PMID: 22549178 Free PMC article.

9

Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation.

Meyer C, Sims AH, Morgan K, Harrison B, Muir M, Bai J, Faratian D, Millar RP, Langdon SP. Meyer C, et al. Among authors: sims ah. Endocr Relat Cancer. 2013 Feb 18;20(1):123-36. doi: 10.1530/ERC-12-0192. Print 2013 Feb. Endocr Relat Cancer. 2013. PMID: 23202794 Free PMC article.

10

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

Turnbull AK, Arthur LM, Renshaw L, Larionov AA, Kay C, Dunbier AK, Thomas JS, Dowsett M, Sims AH, Dixon JM. Turnbull AK, et al. Among authors: sims ah. J Clin Oncol. 2015 Jul 10;33(20):2270-8. doi: 10.1200/JCO.2014.57.8963. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033813 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters